Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

  1. July 12, 2021

    Daiichi Sankyo Unit Says Rival Infringed IP As Trial Opens

    Counsel for a Daiichi Sankyo subsidiary told a California federal jury during trial openings on Monday that Novartis owes royalties for selling drugs that allegedly infringe its billion-dollar skin cancer treatment patents, while Novartis' attorney countered that his client should pay nothing because the patents are invalid.

  2. July 08, 2021

    IP Forecast: Daiichi Sankyo Unit Takes Drug Rival To A Jury

    Attorneys who are vaccinated will be allowed to go maskless before a jury on Monday in a Daiichi Sankyo unit's patent suit in California federal court alleging Novartis is infringing its billion-dollar skin cancer treatment. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.

  3. June 28, 2021

    Vaccinated Attys, Witnesses Can Go Maskless At Calif. IP Trial

    A California federal judge on Friday issued COVID-19 ground rules for an upcoming jury trial on patent infringement claims over a skin cancer treatment, exempting attorneys and witnesses who certify they've been vaccinated from the court's mask mandate.